Voloridge Investment Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-382,472
| Closed | -$4.19M | – | 1654 |
|
|
2023
Q2 | $4.19M | Sell |
382,472
-261,340
| -41% | -$2.86M | 0.02% | 737 |
|
|
2023
Q1 | $5.61M | Buy |
+643,812
| New | +$5.61M | 0.03% | 640 |
|
|
2021
Q1 | – | Sell |
-195,637
| Closed | -$1.12M | – | 1717 |
|
|
2020
Q4 | $1.12M | Sell |
195,637
-197,275
| -50% | -$1.13M | 0.01% | 929 |
|
|
2020
Q3 | $2.85M | Buy |
+392,912
| New | +$2.85M | 0.02% | 603 |
|
|
2020
Q2 | – | Sell |
-34,525
| Closed | -$51K | – | 1568 |
|
|
2020
Q1 | $51K | Sell |
34,525
-57,334
| -62% | -$84.7K | ﹤0.01% | 1042 |
|
|
2019
Q4 | $180K | Buy |
91,859
+27,468
| +43% | +$53.8K | ﹤0.01% | 1009 |
|
|
2019
Q3 | $330K | Buy |
+64,391
| New | +$330K | 0.01% | 902 |
|